Senate

Pharmaceutical executives fielded questions on the costs of insulin and other prescription drugs during a recent hearing of the U.S. Senate Committee on Health, Education, Labor and Pensions.

Members of the U.S. Senate Committee on Health, Education, Labor and Pensions conducted a hearing on May 10 to investigate insulin affordability and what caused prices to increase during the past decade.

Leaders of the U.S. Senate Finance Committee have introduced a bipartisan framework aimed at regulating pharmacy benefit managers as well as to “modernize and enhance” federal prescription drug programs, according to a press release.

A newly introduced bill in the U.S. House of Representatives would require federally funded graduate medical education programs to equitably assess and accept both DO and MD residency candidates, according to a press release.

The Senate has passed legislation that, if signed into law, will lower the cost of some prescription drugs and health insurance in the United States.

Members of the U.S. Senate Committee on Finance grilled leaders of the United Network for Organ Sharing during a recent congressional hearing on poor management of the nation’s organ supply.

The National Kidney Foundation announced support for the House of Representatives Committee on Appropriations in its passing of the Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies bill.

The Senate has confirmed cardiologist Robert Califf, MD, MACC, to lead the FDA for a second time.

The American Psychiatric Association commended provisions made within the $2 trillion Build Back Better Act that are intended to broaden investments needed to boost treatment of mental health and substance use disorders.

The United States Senate on Thursday confirmed Xavier Becerra as HHS secretary.